4//SEC Filing
Berkenblit Anna 4
Accession 0001179110-22-000927
CIK 0000855654other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:31 PM ET
Size
5.4 KB
Accession
0001179110-22-000927
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-04$5.32/sh+311,700$1,658,244→ 311,700 totalExercise: $5.32From: 2023-02-04Exp: 2032-02-04→ Common Stock (311,700 underlying)
Footnotes (1)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001691868
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:31 PM ET
- Size
- 5.4 KB